Emergent BioSolutions
EBS
#7551
Rank
ยฃ0.32 B
Marketcap
ยฃ6.21
Share price
-0.83%
Change (1 day)
27.47%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): ยฃ0.12 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are ยฃ0.75 Billion. In 2024 the company made an earning of -ยฃ53.63 Million, an increase over its 2023 earnings that were of -ยฃ0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.12 B-334.11%
2024 -ยฃ53.63 Million-88.82%
2023 -ยฃ0.48 Billion242.73%
2022 -ยฃ0.14 Billion-153.8%
2021 ยฃ0.26 B-20.43%
2020 ยฃ0.32 B278.02%
2019 ยฃ86.51 M27.11%
2018 ยฃ68.06 M-27.12%
2017 ยฃ93.39 M17.21%
2016 ยฃ79.68 M0.45%
2015 ยฃ79.33 M73.51%
2014 ยฃ45.72 M41.36%
2013 ยฃ32.34 M35.2%
2012 ยฃ23.92 M0.4%
2011 ยฃ23.82 M-56.46%
2010 ยฃ54.72 M76.73%
2009 ยฃ30.96 M32.94%
2008 ยฃ23.29 M-5.62%
2007 ยฃ24.68 M
2005 ยฃ35.73 M269.89%
2004 ยฃ9.66 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.89 B 6,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.80 B 7,856.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ7.46 B 5,956.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-ยฃ9.23 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
ยฃ67.34 M-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.69 B 1,273.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel